Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Disruption of PDEs has been associated with a number of adrenal diseases
High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875
4]dioxetan]-3'-yl}phenoxy)phosphonic acid
which is in Phase 3 trials
InChi: InChI=1S/C16H16F3N5O5/c17-16(18
5-PA-dUTP Catalog No.:M26008-C Disruption of PDEs has been5 PA dUTP (5 Propargylamino dUTP) is a C5 modified nucleotide and can be incorporated into DNA nanoparticles (DNPs) for photosensitizer delivery. Product information CAS Number: 179101 49 6 Molecular Weight: 521. 20 Formula: C12H18N3O14P3 Chemical Name: ({[({[(2R,3S,5R) 5 [5 (3 aminoprop 1 yn 1 yl) 2,4 dioxo 1,2,3,4 tetrahydropyrimidin 1 yl] 3 hydroxyoxolan 2 yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid Smiles:
US$ 110.00
US$ 66.00
US$ 73.00
US$ 197.50
US$ 147.50
US$ 160.47
US$ 112.50
US$ 325.00
US$ 3488.50
US$ 155.00
US$ 167.00
US$ 276.00
US$ 129.95